Open original FDA record ↗Recall record
- FDA identifier
- Z-0230-04
- Company in FDA record
- Abbott Laboratories HPD/ADD/GPRD
- FDA classification date
- Dec 17, 2003
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 20, 2026
- Recall classification
- Unknown — no matched enforcement classification
Reason stated in the source
Inadequate instructions for use resulting in calibration errors and the protein interference data in the package insert is not representative of assay performances.
Source facts
- Action
- Device correction recall initiated by letters dated 11/12/03. Letters were sent to all current IMx Tacrolimus II customers worldwide, advising them that calibration errors and controls out of range be the result of variance with the sample pretreatment steps listed in the package insert, and that the protein interference data in the insert is not representative of assay performance (12% when it should state less than 22% error) . A Customer Training Guide was included in the letter, outlining steps to aid the assay user in performing the pretreatment step and listing the most common deviations that can impact results.
- Initiated
- 2003-11-13
- Root cause
- Other
- Terminated
- 2004-10-29
- Distribution
- Nationwide and internationally to Guatemala, Venezuela, Columbia, Peru, Chile, Australia, Panama, Argentina, Puerto Rico, Dominican Republic, Canada, Germany, New Zealand, England, Japan, Singapore, Thailand, Korea and Costa Rica.
- Recall number
- Z-0230-04
- Recall status
- Terminated
- CDRH record ID
- 30404
- FDA classified
- 2003-12-17
- Recall event number
- 27717